| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |